03/16/2026
Colin Kiesel, who has stage 4 pancreatic cancer, is the first patient in Colorado to take Zenocutuzumab, a recently FDA-approved targeted therapy. Studies have shown the drug could help some patients for multiple years. Kiesel has been on the treatment for about six months.
“I know my experience getting this will benefit families in the future,” he said. “They can look on this and feel some hope that, hey, there might be another option for me.”
Read more of Kiesel's story in this 9NEWS (KUSA) ⬇️
https://bit.ly/4bFmOQG
A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.